Katherine Watkins is a Substance Abuse Treatment and Outcomes physician affiliated with RAND Corporation. OpenAlex indexes 219 publications with 4,483 citations (h-index 31); ClinicalTrials.gov lists 5 registered studies with this person as an investigator.
Data verified 23 Oct 2026
Overview
Updated 23 Oct 2026
Katherine Watkins, MD, is affiliated with RAND Corporation. The public record shows 219 publications with 4,483 citations (h-index 31), centered on Substance Abuse Treatment and Outcomes, Opioid Use Disorder Treatment, Mental Health Treatment and Access. It also documents an investigator role on 5 registered clinical trials, 10 NIH-funded awards (2005–2026).
- Most recent indexed publication: 2026 · Public health reports (Washington, D.C.
- Top research focus: Substance Abuse Treatment and Outcomes
- 5 registered trials on ClinicalTrials.gov
Generated from the cited public record · current as of 23 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 4 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 77.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 23 Oct 2026
Listed as an investigator on 5 registered studies on ClinicalTrials.gov. The most recent:
Industry payments
No payments involving this person were reported to CMS in program years 2021–2024. Why? →
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
100%Aminoketone25.8%Bupropion Xl100%Part D<11 patientsSSRI23.9%Fluoxetine Hcl100%Part D<11 patients+ 4 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 23 Oct 2026
10 NIH research awards on record, funded 2005–2026 per NIH RePORTER. The latest:
- Reducing Overdose and Suicide Risk in Individuals with OUD and Co-occurring Disorders
Rand Corporation
FY2026$625,037R01DA056588 - Reducing Overdose and Suicide Risk in Individuals with OUD and Co-occurring Disorders
Rand Corporation
FY2025$618,652R01DA056588
Publications
Updated 23 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Framework for the Opioid Use Disorder Cascade of Care: Adaptation and Application for a Large Municipal Health System.
Public health reports (Washington, D.C.
Article2026 - Reducing opioid prescriptions does not increase rate of refills or new opioid requests: evidence from a randomized trial.
Health affairs scholar
Article2026 - Examining how support persons' buprenorphine attitudes and their communication about substance use impacts patient well-being.
The American journal of drug and alcohol abuse
Article2025
Most-cited works
by citation count (OpenAlex)- 01Health Information on the InternetArticle1,212 citations2001
- 02Collaborative Care for Opioid and Alcohol Use Disorders in Primary CareArticle229 citations2017
- 03
- 04A National Survey of Care for Persons With Co-occurring Mental and Substance Use DisordersArticle177 citations2001
- 05
Network
Updated 23 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Similar KOLs
Other experts from the same institution or the same specialty.
Alicia Ruelaz Maher, MD
RAND Corporation
Curley Bonds, MD
RAND Corporation
Charles Nemeroff, MD
Dell Medical School
Maurizio Fava, MD
Massachusetts General Hospital
John Krystal, MD
Yale University
Raquel Gur, MD
University of Pennsylvania